Diagnostic test: functional residual capacity    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
294Congenital diaphragmatic hernia1

294. Congenital diaphragmatic hernia    [ 12 clinical trials,   29 drugs,   (DrugBank: 6 drugs),   5 drug target genes,   14 drug target pathways]
Searched query = "Congenital diaphragmatic hernia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 12 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03787160
(ClinicalTrials.gov)
March 22, 201810/7/2018Microbiome and Volatile Organic Compounds in Patients With CDHDetermining the Effect of Probiotics on Microbiome and Volatile Organic Compounds in Patients After Surgical Repair of Congenital Diaphragmatic HerniaCongenital Diaphragmatic HerniaDiagnostic Test: initial VOC;Diagnostic Test: initial fecal microbiome;Diagnostic Test: initial pulmonary microbiome;Diagnostic Test: Maximum oxygen uptake;Diagnostic Test: Functional residual capacity;Dietary Supplement: Probiotic treatment;Diagnostic Test: VOC probiotic;Diagnostic Test: Fecal microbiome probiotic;Diagnostic Test: Pulmonary microbiome probioticMedical University of GrazUniversity of RostockCompleted6 Years16 YearsAll18N/AAustria